在COVID-19大流行之前和期间,亚洲国家和地区的重症监护病床容量:一项观察性研究
Jason Phua1,2, Atul Prabhakar Kulkarni3, Toshiyuki Mizota4
1Fast and Chronic Programmes, Alexandra Hospital, National University Health System, Singapore.
The Lancet regional health. Western Pacific
|December 25, 2023
概括
亚洲国家的重症监护病床容量在2017年至2022年之间几乎增加了三倍,主要是由于中等收入经济体的推动. 这项研究追踪了人均重症监护病房和中等护理病房的病床数量,揭示了COVID-19流行后的显著增长.
科学领域:
- 关键护理医学 关键护理医学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 随着COVID-19的爆发,人们越来越需要强大的重症监护基础设施.
- 了解重症监护病床容量的变化对于疫情准备至关重要.
研究的目的:
- 为了比较亚洲国家的成人重症监护病床人均数量,在2017年之前 (2022年) 和COVID-19大流行期间.
- 分析亚洲不同收入经济体的重症监护病床供应趋势.
主要方法:
- 一项观察性研究收集了12个中等收入和7个高收入亚洲经济体的重症监护病床 (ICU和中等护理) 的数据.
- 数据从政府来源,国家协会,个人联系和推断中收集,将2022年的数据与2017年的基线进行比较.
- 世界银行分类 (2022-2023) 用于对经济进行分类.
主要成果:
- 每10万人口的累计重症监护病床数量从2017年的3.0个增加到2022年的9.4个 (p=0.003).
- 人均床位中位数在中等收入经济体 (2.6至6.6) 和高收入经济体 (11.4至13.9) 上升.
- 在2022年,10.9%的床位是单人房,5.3%的床位有负压,收入群体之间存在差异.
结论:
- 研究亚洲地区的重症监护病床容量在2017年至2022年之间几乎翻了三倍.
- 中等收入经济体对这一增长做出了重大贡献,尽管存在相当大的异质性.
- 调查结果突出显示,亚洲大流行后重症监护基础设施得到了大幅改善.
相关概念视频
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
01:21Acute Respiratory Failure-II
238
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
238
01:28Current Trends in Nursing I
1.5K
Current trends in nursing include:
1.5K
01:30Acute Respiratory Failure-III
187
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187
01:21Acute Respiratory Failure-I
213
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
213
01:29Acute Respiratory Failure-V
142
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142